A new report analyses a vast trove of data on diabetes, studying the effects of more intense control of blood sugar based upon age and medical conditions. The answers are not clear.
The association between cataracts the clouding of the lens of the eye and taking statins the widely used cholesterol-lowering drug class has been studied in the past and results have been inconsistent and controversial. A new observational study conducted by researchers from the University of British Columbia led
A new study suggests that diabetes prevention and glucose control in middle age may protect against cognitive decline. The study, from Johns Hopkins Bloomberg School of Public Health, was published December 2nd in Annals of Internal Medicine.
A large study from Japan shows no significant protective effect of low-dose aspirin against cardiovascular mortality among people with risk factors (but no prior CVD history). Now what should doctors advise?
Last June, California lawmakers introduced a bill requiring soft drinks to be labeled with a warning linking the drinks to obesity, diabetes and tooth decay. The bill was defeated by the state assembly. Now New York is
Bariatric surgery is perhaps the most effective means of combatting obesity, and according to the Journal of the American College of Surgery, some form of that surgery was chosen by over 120,000 people in 2008. There is, however, more than one type of bariatric surgery, and until recently it wasn t clear which would be better in terms of post-operative complications, the rate of re-hospitalization, or the efficacy of different procedures.
The benefits of bariatric surgery for weight loss and remission of type 2 diabetes have been studied extensively. However, questions remain as
Even if your blood glucose levels don t indicate diabetes, that s no reason to ignore the possibility of developing this increasingly common disease.
We ve commented before on studies that demonstrate the benefits of bariatric surgery for weight loss and remission of type 2 diabetes. Most of these studies have not followed the participants for more than a few years, leaving open the question of whether or not these benefits are maintained. A new study, one that followed participants for 18 years, has just been published in the latest edition of JAMA.
Catch the latest news on unnecessary warning labels on sugary drinks, why GM labeling is not needed, and why cases of measles have climbed to an all-time high.